KCTD8 anticorps (AA 381-473) (AbBy Fluor® 350)
-
- Antigène Voir toutes KCTD8 Anticorps
- KCTD8 (Potassium Channel Tetramerisation Domain Containing 8 (KCTD8))
-
Épitope
- AA 381-473
- Reactivité
- Humain, Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp KCTD8 est conjugé à/à la AbBy Fluor® 350
-
Application
- Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Réactivité croisée
- Humain, Souris
- Homologie
- Rat,Dog,Cow,Sheep,Pig,Horse,Chicken,Rabbit
- Purification
- Purified by Protein A.
- Immunogène
- KLH conjugated synthetic peptide derived from human KCTD8
- Isotype
- IgG
- Top Product
- Discover our top product KCTD8 Anticorps primaire
-
-
- Indications d'application
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Date de péremption
- 12 months
-
- Antigène
- KCTD8 (Potassium Channel Tetramerisation Domain Containing 8 (KCTD8))
- Autre désignation
- KCTD8 (KCTD8 Produits)
- Synonymes
- anticorps A730087N02Rik, anticorps potassium channel tetramerisation domain containing 8, anticorps potassium channel tetramerization domain containing 8, anticorps Kctd8, anticorps KCTD8
- Sujet
-
Synonyms: BTB/POZ domain-containing protein KCTD8, KCTD8, KCTD8_HUMAN, Potassium channel tetramerisation domain containing 8.
Background: Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization.
- Pathways
- Regulation of G-Protein Coupled Receptor Protein Signaling
-